What to Expect From Eli Lilly’s Q4 2025 Earnings Report

Boasting a market cap of $1 trillion, Eli Lilly and Company (LLY) is a major global research-based pharmaceutical company that discovers, develops, manufactures, and markets a broad portfolio of prescription medicines. Founded in 1876 and headquartered in Indianapolis, Indiana, Lilly’s product lineup comprises leading treatments such as Mounjaro and Zepbound for type 2 diabetes and weight management, Trulicity and Jardiance for diabetes, Verzenio for cancer, Taltz for autoimmune conditions, and established ...